Literature DB >> 17553121

Severe epilepsy in X-linked creatine transporter defect (CRTR-D).

Maria Margherita Mancardi1, Ubaldo Caruso, Maria Cristina Schiaffino, Maria Giuseppina Baglietto, Andrea Rossi, Francesca Maria Battaglia, Gajja Sophi Salomons, Cornelis Jakobs, Federico Zara, Edvige Veneselli, Roberto Gaggero.   

Abstract

Disorders of creatine synthesis or its transporter resulting in neurological impairment with mental retardation and epilepsy have only been recognized in recent years. To date, the epileptic disorder observed in creatine transporter deficiency (CRTR-D) has been described as a mild phenotype with infrequent seizures and favorable response to common antiepileptic drugs. We report on a 5 year-old boy with known speech delay who presented with severe and refractory epilepsy. After extensive investigations, metabolite analysis and brain 1H-MRS suggested CRTR-D, which was confirmed by the detection of a known pathogenic mutation in the SLC6A8 gene (c.1631C>T; p.Pro544Leu).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17553121     DOI: 10.1111/j.1528-1167.2007.01148.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  13 in total

1.  Downregulation of the creatine transporter SLC6A8 by JAK2.

Authors:  Manzar Shojaiefard; Zohreh Hosseinzadeh; Shefalee K Bhavsar; Florian Lang
Journal:  J Membr Biol       Date:  2012-03-11       Impact factor: 1.843

2.  Expression and distribution of creatine transporter and creatine kinase (brain isoform) in developing and mature rat cochlear tissues.

Authors:  Ann Chi Yan Wong; Sailakshmi Velamoor; Matthew R Skelton; Peter R Thorne; Srdjan M Vlajkovic
Journal:  Histochem Cell Biol       Date:  2012-02-04       Impact factor: 4.304

Review 3.  Solute Carriers in the Blood-Brain Barier: Safety in Abundance.

Authors:  Katarzyna A Nałęcz
Journal:  Neurochem Res       Date:  2016-08-09       Impact factor: 3.996

Review 4.  X-linked creatine transporter deficiency: clinical aspects and pathophysiology.

Authors:  Jiddeke M van de Kamp; Grazia M Mancini; Gajja S Salomons
Journal:  J Inherit Metab Dis       Date:  2014-05-01       Impact factor: 4.982

5.  A Novel SLC6A8 Mutation in a Large Family with X-Linked Intellectual Disability: Clinical and Proton Magnetic Resonance Spectroscopy Data of Both Hemizygous Males and Heterozygous Females.

Authors:  S Dreha-Kulaczewski; V Kalscheuer; A Tzschach; H Hu; G Helms; K Brockmann; A Weddige; P Dechent; G Schlüter; R Krätzner; H-H Ropers; J Gärtner; B Zirn
Journal:  JIMD Rep       Date:  2013-11-05

Review 6.  Creatine transporter deficiency in two adult patients with static encephalopathy.

Authors:  A Sempere; C Fons; A Arias; P Rodríguez-Pombo; R Colomer; B Merinero; P Alcaide; A Capdevila; A Ribes; R Artuch; J Campistol
Journal:  J Inherit Metab Dis       Date:  2009-03-25       Impact factor: 4.982

Review 7.  AGAT, GAMT and SLC6A8 distribution in the central nervous system, in relation to creatine deficiency syndromes: a review.

Authors:  O Braissant; H Henry
Journal:  J Inherit Metab Dis       Date:  2008-04-04       Impact factor: 4.982

8.  Neuropsychological profile and clinical effects of arginine treatment in children with creatine transport deficiency.

Authors:  Annamaria Chilosi; Manuela Casarano; Alessandro Comparini; Francesca Maria Battaglia; Margherita Maria Mancardi; Cristina Schiaffino; Michela Tosetti; Vincenzo Leuzzi; Roberta Battini; Giovanni Cioni
Journal:  Orphanet J Rare Dis       Date:  2012-06-19       Impact factor: 4.123

9.  Transport characteristics of guanidino compounds at the blood-brain barrier and blood-cerebrospinal fluid barrier: relevance to neural disorders.

Authors:  Masanori Tachikawa; Ken-Ichi Hosoya
Journal:  Fluids Barriers CNS       Date:  2011-02-28

10.  Creatine transporter (CrT; Slc6a8) knockout mice as a model of human CrT deficiency.

Authors:  Matthew R Skelton; Tori L Schaefer; Devon L Graham; Ton J Degrauw; Joseph F Clark; Michael T Williams; Charles V Vorhees
Journal:  PLoS One       Date:  2011-01-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.